Papers: 2 May 2014 - 9 May 2014 Check out this week's papers from PubMed. If you are a member, please log in to recommend and comment on papers. If you are not a member, please register today and join the conversation. Papers: Editors' Pick Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. Cruz-Orengo L, Daniels BP, Dorsey D, Basak S A, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, et al. J Clin Invest. 2014 May 8. Epub 1969 Dec 31. PMID: 24812668. Abstract Editors' Pick Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis. Gava G, Bartolomei I, Costantino A, Berra M, Venturoli S, Salvi F, Meriggiola M C Fertil Steril. 2014 Apr 29. PMID: 24794311. Abstract Editors' Pick The clinical impact of cerebellar grey matter pathology in multiple sclerosis. Damasceno A, Damasceno B P, Cendes F PLoS One. 2014; 9(5):e96193. Epub 2014 May 02. PMID: 24789257. Abstract Editors' Pick The refinement of genetic predictors of multiple sclerosis. Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G PLoS One. 2014; 9(5):e96578. Epub 2014 May 02. PMID: 24794218. Abstract Incidence of the urological tumours in patients suffering from multiple sclerosis. Krhut J, Hradilek P, Nemec D, Tvrdik J, Zapletalova O, Zvara P Acta Neurol Scand. 2014 May 8. PMID: 24810630. Abstract Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections. Ahmed CM, Johnson HM J Interferon Cytokine Res. 2014 May 8. PMID: 24811478. Abstract Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence? Cutter GR, Stüve O Mult Scler. 2014 May 8. PMID: 24812045. Abstract Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability. Daams M, Weiler F, Steenwijk MD, Hahn HK, Geurts JJG, Vrenken H, van Schijndel RA, Balk LJ, Tewarie PK, Tillema J-M, et al. Mult Scler. 2014 May 8. PMID: 24812042. Abstract The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis. Hupperts R, Ghazi-Visser L, Silva A M, Arvanitis M, Kuusisto H, Marhardt K, Vlaikidis N, for the STAR Study Group Clin Ther. 2014 May 5. PMID: 24811754. Abstract The role of microglial activation in disease progression. Correale J Mult Scler. 2014 May 8. PMID: 24812046. Abstract Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? Rotondi M, Bergamaschi R, Chiovato L Mult Scler. 2014 May 8. PMID: 24812044. Abstract Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors. Cui Q L, Fang J, Kennedy TE, Almazan G, Antel JP Glia. 2014 May 9. PMID: 24810969. Abstract Management of pain in advanced disease. Harris DG Br Med Bull. 2014 May 7. PMID: 24810848. Abstract Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis. Verbout NG, Yu X, Healy LD, Phillips KG, Tucker EI, Gruber A, McCarty O J, Offner H Metab Brain Dis. 2014 May 9. PMID: 24810631. Abstract Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis. Göbel K, Schuhmann MK, Pankratz S, Stegner D, Herrmann AM, Braun A, Breuer J, Bittner S, Ruck T, Wiendl H, et al. Eur J Immunol. 2014 May 8. PMID: 24811005. Abstract Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study. Clemenzi A, Pompa A, Casillo P, Pace L, Troisi E, Catani S, Grasso M G Med Sci Monit. 2014; 20:758-66. PMID: 24811853. Abstract Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study. Thomas S, Fazakarley L, Thomas PW, Brenton S, Collyer S, Perring S, Scott R, Galvin K, Hillier C BMJ Open. 2014; 4(5):e005172. PMID: 24812193. Abstract Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis. Kohn CG, Coleman CI, White MC, Sidovar MF, Sobieraj DM Curr Med Res Opin. 2014 May 6. PMID: 24803286. Abstract Vital role of specialist MS nurses recognised in proposed guideline. Kleebauer A Nurs Stand. 2014 May 7; 28(36):11. PMID: 24802430. Abstract Linked in and up to speed. Nurs Stand. 2014 May 7; 28(36):63. PMID: 24802482. Abstract Support our campaign for better treatment for people with MS. Mitchell M Nurs Stand. 2014 May 7; 28(36):34-5. PMID: 24802459. Abstract Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase. Kobayashi M, Nanri K, Taguchi T, Ishiko T, Yoshida M, Yoshikawa N, Sugisaki K, Tanaka N J Clin Apher. 2014 May 6. PMID: 24802352. Abstract Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review. Moens K, Higginson IJ, Harding R, EURO IMPACT J Pain Symptom Manage. 2014 May 3. PMID: 24801658. Abstract Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, Giuliani F J Neurosci Res. 2014 May 7. PMID: 24801011. Abstract Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. Zhu D, Liu M, Yang Y, Ma L, Jiang Y, Zhou L, Huang Q, Pi R, Chen X J Neurosci Res. 2014 May 2. PMID: 24798871. Abstract Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Ragerdi Kashani I, Rajabi Z, Akbari M, Hassanzadeh G, Mohseni A, Eramsadati M K, Rafiee K, Beyer C, Kipp M, Zendedel A Exp Brain Res. 2014 May 6. PMID: 24798398. Abstract Trunk kinematics during walking in persons with multiple sclerosis: The influence of body weight support. Swinnen E, Baeyens J-P, Pintens S, Van Nieuwenhoven J, Ilsbroukx S, Buyl R, Goossens M, Meeusen R, Kerckhofs E NeuroRehabilitation. 2014 May 5. PMID: 24796441. Abstract Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE. Donegà M, Giusto E, Cossetti C, Schaeffer J, Pluchino S J Vis Exp. 2014(86). PMID: 24798882. Abstract Autoimmune Hepatitis-like reaction developing in a patient treated with Interferon beta 1a. Mishra A, Guindi M, Kandel G, Streutker CJ Histopathology. 2014 May 5. PMID: 24796493. Abstract Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1. Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, et al. J Neuroimmunol. 2014 Apr 16. PMID: 24798244. Abstract Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review. Bohannon RW, Glenney SS J Eval Clin Pract. 2014 May 5. PMID: 24798823. Abstract Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate. Kulakova OG, Tsareva E Y, Lvovs D, Favorov AV, Boyko AN, Favorova OO Pharmacogenomics. 2014 Apr; 15(5):679-85. PMID: 24798724. Abstract Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis. Bulley C, Mercer TH, Hooper JE, Cowan P, Scott S, van der Linden ML Disabil Rehabil Assist Technol. 2014 May 6. PMID: 24796365. Abstract Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice. Bittner S, Afzali AM, Wiendl H, Meuth SG J Vis Exp. 2014(86). PMID: 24797125. Abstract Quality of life in Polish patients with multiple sclerosis. Mitosek-Szewczyk K, Kułakowska A, Bartosik-Psujek H, Hożejowski R, Drozdowski W, Stelmasiak Z Adv Med Sci. 2014 Mar; 59(1):34-8. PMID: 24797971. Abstract Multiple sclerosis care in Latin America. Rivera VM, Medina M T, Duron RM, Macias M A Neurology. 2014 May 6; 82(18):1660-1. PMID: 24799516. Abstract Vitamin D and multiple sclerosis. Harandi A A, Harandi A A, Pakdaman H, Sahraian M A Iran J Neurol. 2014; 13(1):1-6. PMID: 24800040. Abstract Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica. Etemadifar M, Mehrbod N, Dehghani L, Golabbakhsh A, Fereidan-Esfahani M, Akbari M, Nasr Z Iran J Neurol. 2014; 13(1):50-1. PMID: 24800049. Abstract Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients. Bitarafan S, Harirchian M-H, Nafissi S, Sahraian M-A, Togha M, Siassi F, Saedisomeolia A, Alipour E, Mohammadpour N, Chamary M, et al. Iran J Neurol. 2014; 13(1):28-32. PMID: 24800044. Abstract Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse. Wang X-S, Fang H-L, Chen Y, Liang S-S, Zhu Z-G, Zeng Q-Y, Li J, Xu H-Q, Shao B, He J-C, et al. Eur J Pharmacol. 2014 May 2. PMID: 24797785. Abstract Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis. Harirchian M H, Sahraian M A, Hosseinkhani A, Amirzargar N Iran J Neurol. 2014; 13(1):13-8. PMID: 24800042. Abstract Diffusion tensor MRI as a biomarker in axonal and myelin damage. Aung W Y, Mar S, Benzinger T L Imaging Med. 2013 Oct 1; 5(5):427-440. PMID: 24795779. Abstract Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink? Filippi M, Preziosa P, Rocca MA Curr Opin Neurol. 2014 Jun; 27(3):290-9. PMID: 24792339. Abstract The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis. Fritz NE, Marasigan R ER, Calabresi PA, Newsome SD, Zackowski KM Neurorehabil Neural Repair. 2014 May 1. PMID: 24795162. Abstract Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, et al. Lancet Neurol. 2014 Apr 30. PMID: 24794721. Abstract Activation-induced cell death in T lymphocytes from multiple sclerosis patients. Moreno M, Negrotto L, Río J, Moubarak R, Martín I, Bustamante MF, Comella JX, Vidal-Jordana A, Pérez-Boza J, Montalban X, et al. J Neuroimmunol. 2014 Apr 16. PMID: 24793898. Abstract Mode of action and clinical studies with alemtuzumab. Jones JL, Coles AJ Exp Neurol. 2014 May 2. PMID: 24792641. Abstract Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott C A, Enzinger C, et al. Mult Scler. 2014 Apr 30. PMID: 24787429. Abstract No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population. Namgoong S, Bae JS, Cheong HS, Kim J-H, Kim JY, Kim LH, Kim HJ, Shin HD Tissue Antigens. 2014 May 2. PMID: 24786287. Abstract Effects of cannabis on cognition in patients with MS: A psychometric and MRI study. Pavisian B, Macintosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A Neurology. 2014 Apr 30. PMID: 24789863. Abstract Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study. Simpson S, Stewart N, van der Mei I, Otahal P, Charlesworth J, Ponsonby A-L, Blizzard L, Dwyer T, Pittas F, Gies P, et al. J Neurol Neurosurg Psychiatry. 2014 May 1. PMID: 24790215. Abstract Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis. Prosperini L, De Angelis F, De Angelis R, Fanelli F, Pozzilli C J Neurol Neurosurg Psychiatry. 2014 Apr 30. PMID: 24790213. Abstract Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study. Jongen P J, Lehnick D, Koeman J, Frequin S, Heersema D, Kornips B, Schyns-Soeterboek A, Visser LH, Schiphof P, Valkenburg A, et al. J Neurol. 2014 May 3. Epub 2014 May 03. PMID: 24792727. Abstract Retinal architecture and mfERG: Optic nerve head component response characteristics in MS. Schnurman ZS, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, et al. Neurology. 2014 Apr 30. PMID: 24789865. Abstract Teriflunomide - a new oral agent for multiple sclerosis treatment. Antochi F Maedica (Buchar). 2013 Sep; 8(4):404-5. PMID: 24790678. Abstract Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis. Piffer S, Turri G, Acler M, Richelli S, Cerini R, Fiaschi A, Monaco S, Bonetti B J Neurol Sci. 2014 Apr 13. PMID: 24780438. Abstract An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis. Yang H-Q, Zhao W-C, Feng S-M, Ma J-J Intern Med. 2014; 53(9):1011-5. Epub 2014 May 01. PMID: 24785895. Abstract Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis. Jongen P J, Wesnes K, van Geel B, Pop P, Sanders E, Schrijver H, Visser LH, Gilhuis JH, Sinnige LG, Brands AM, et al. PLoS One. 2014; 9(5):e96444. Epub 2014 May 01. PMID: 24787714. Abstract ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9. Zheng M, Wei J, Tang Y, Yang C, Wei Y, Yin X, Liu Q J Mol Neurosci. 2014 May 1. Epub 2014 May 01. PMID: 24788224. Abstract miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Honardoost M A, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M Gene. 2014 Jul 10; 544(2):128-33. Epub 2014 Apr 30. PMID: 24792898. Abstract Fumaric acid esters in psoriasis and multiple sclerosis. Zecca C, Caporro M, Adami M, Mainetti C, Gobbi C Clin Exp Dermatol. 2014 Jun; 39(4):488-91. Epub 2014 Apr 30. PMID: 24779791. Abstract Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis. Fissolo N, Cantó E, Vidal-Jordana A, Castilló J, Montalban X, Comabella M J Neuroimmunol. 2014 Jun 15; 271(1-2):56-9. Epub 2014 Apr 16. PMID: 24794503. Abstract No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis. Guerini FR, Clerici M, Cagliani R, Malhotra S, Montalban X, Forni D, Agliardi C, Riva S, Caputo D, Galimberti D, et al. J Neuroimmunol. 2014 Jun 15; 271(1-2):49-52. Epub 2014 Apr 16. PMID: 24794504. Abstract The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB J Neurol Sci. 2014 Jun 15; 341(1-2):79-84. Epub 2014 Apr 13. PMID: 24792098. Abstract Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. Shin S, Walz KA, Archambault AS, Sim J, Bollman BP, Koenigsknecht-Talboo J, Cross AH, Holtzman DM, Wu GF J Neuroimmunol. 2014 Jun 15; 271(1-2):8-17. Epub 2014 Mar 29. PMID: 24794230. Abstract Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study. Kataoka H, Kiriyama T, Taoka T, Oba N, Takewa M, Eura N, Syobatake R, Kobayashi Y, Kumazawa M, Izumi T, et al. Clin Neurol Neurosurg. 2014 Jun; 121:55-8. Epub 2014 Mar 27. PMID: 24793476. Abstract Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis. Prosperini L, Giannì C, Fortuna D, Marchetti M R, Pozzilli C Mult Scler Int. 2014; 2014:802307. Epub 2014 Mar 27. PMID: 24800078. Abstract Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. Rao SM, Martin AL, Huelin R, Wissinger E, Khankhel Z, Kim E, Fahrbach K Mult Scler Int. 2014; 2014:975803. Epub 2014 Mar 25. PMID: 24795824. Abstract Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Nikseresht A, Sharifian M, Izadi S, Hamidian Jahromi A, Rezaianzadeh A Clin Neurol Neurosurg. 2014 Jun; 121:23-6. Epub 2014 Mar 19. PMID: 24793469. Abstract Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication. Lunardelli A, Sartori A, Mengotti P, Rumiati RI, Pesavento V Behav Neurol. 2014; 2014:873541. Epub 2014 Feb 18. PMID: 24803736. Abstract Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis. Tse HY, Li J, Zhao X, Chen F, Ho PP, Shaw MK Curr Trends Immunol. 2012; 13:1-12. PMID: 24795508. Abstract
Editors' Pick Enhanced sphingosine-1-phosphate receptor 2 expression underlies female CNS autoimmunity susceptibility. Cruz-Orengo L, Daniels BP, Dorsey D, Basak S A, Grajales-Reyes JG, McCandless EE, Piccio L, Schmidt RE, Cross AH, Crosby SD, et al. J Clin Invest. 2014 May 8. Epub 1969 Dec 31. PMID: 24812668. Abstract
Editors' Pick Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis. Gava G, Bartolomei I, Costantino A, Berra M, Venturoli S, Salvi F, Meriggiola M C Fertil Steril. 2014 Apr 29. PMID: 24794311. Abstract
Editors' Pick The clinical impact of cerebellar grey matter pathology in multiple sclerosis. Damasceno A, Damasceno B P, Cendes F PLoS One. 2014; 9(5):e96193. Epub 2014 May 02. PMID: 24789257. Abstract
Editors' Pick The refinement of genetic predictors of multiple sclerosis. Disanto G, Dobson R, Pakpoor J, Elangovan RI, Adiutori R, Kuhle J, Giovannoni G PLoS One. 2014; 9(5):e96578. Epub 2014 May 02. PMID: 24794218. Abstract
Incidence of the urological tumours in patients suffering from multiple sclerosis. Krhut J, Hradilek P, Nemec D, Tvrdik J, Zapletalova O, Zvara P Acta Neurol Scand. 2014 May 8. PMID: 24810630. Abstract
Short Peptide Type I Interferon Mimetics; Therapeutics for Experimental Allergic Encephalomyelitis, Melanoma, and Viral Infections. Ahmed CM, Johnson HM J Interferon Cytokine Res. 2014 May 8. PMID: 24811478. Abstract
Does risk stratification decrease the risk of natalizumab-associated PML? Where is the evidence? Cutter GR, Stüve O Mult Scler. 2014 May 8. PMID: 24812045. Abstract
Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability. Daams M, Weiler F, Steenwijk MD, Hahn HK, Geurts JJG, Vrenken H, van Schijndel RA, Balk LJ, Tewarie PK, Tillema J-M, et al. Mult Scler. 2014 May 8. PMID: 24812042. Abstract
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis. Hupperts R, Ghazi-Visser L, Silva A M, Arvanitis M, Kuusisto H, Marhardt K, Vlaikidis N, for the STAR Study Group Clin Ther. 2014 May 5. PMID: 24811754. Abstract
The role of microglial activation in disease progression. Correale J Mult Scler. 2014 May 8. PMID: 24812046. Abstract
Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate? Rotondi M, Bergamaschi R, Chiovato L Mult Scler. 2014 May 8. PMID: 24812044. Abstract
Role of p38MAPK in S1P receptor-mediated differentiation of human oligodendrocyte progenitors. Cui Q L, Fang J, Kennedy TE, Almazan G, Antel JP Glia. 2014 May 9. PMID: 24810969. Abstract
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis. Verbout NG, Yu X, Healy LD, Phillips KG, Tucker EI, Gruber A, McCarty O J, Offner H Metab Brain Dis. 2014 May 9. PMID: 24810631. Abstract
Phospholipase D1 mediates lymphocyte adhesion and migration in experimental autoimmune encephalomyelitis. Göbel K, Schuhmann MK, Pankratz S, Stegner D, Herrmann AM, Braun A, Breuer J, Bittner S, Ruck T, Wiendl H, et al. Eur J Immunol. 2014 May 8. PMID: 24811005. Abstract
Chronic pain in multiple sclerosis: Is there also fibromyalgia? An observational study. Clemenzi A, Pompa A, Casillo P, Pace L, Troisi E, Catani S, Grasso M G Med Sci Monit. 2014; 20:758-66. PMID: 24811853. Abstract
Testing the feasibility and acceptability of using the Nintendo Wii in the home to increase activity levels, vitality and well-being in people with multiple sclerosis (Mii-vitaliSe): protocol for a pilot randomised controlled study. Thomas S, Fazakarley L, Thomas PW, Brenton S, Collyer S, Perring S, Scott R, Galvin K, Hillier C BMJ Open. 2014; 4(5):e005172. PMID: 24812193. Abstract
Mobility, Walking And Physical Activity In Persons With Multiple Sclerosis. Kohn CG, Coleman CI, White MC, Sidovar MF, Sobieraj DM Curr Med Res Opin. 2014 May 6. PMID: 24803286. Abstract
Vital role of specialist MS nurses recognised in proposed guideline. Kleebauer A Nurs Stand. 2014 May 7; 28(36):11. PMID: 24802430. Abstract
Support our campaign for better treatment for people with MS. Mitchell M Nurs Stand. 2014 May 7; 28(36):34-5. PMID: 24802459. Abstract
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase. Kobayashi M, Nanri K, Taguchi T, Ishiko T, Yoshida M, Yoshikawa N, Sugisaki K, Tanaka N J Clin Apher. 2014 May 6. PMID: 24802352. Abstract
Are There Differences in the Prevalence of Palliative Care-Related Problems in People Living With Advanced Cancer and Eight Non-Cancer Conditions? A Systematic Review. Moens K, Higginson IJ, Harding R, EURO IMPACT J Pain Symptom Manage. 2014 May 3. PMID: 24801658. Abstract
Characterization of the NT2-derived neuronal and astrocytic cell lines as alternative in vitro models for primary human neurons and astrocytes. Haile Y, Fu W, Shi B, Westaway D, Baker G, Jhamandas J, Giuliani F J Neurosci Res. 2014 May 7. PMID: 24801011. Abstract
Ginsenoside Rd ameliorates experimental autoimmune encephalomyelitis in C57BL/6 mice. Zhu D, Liu M, Yang Y, Ma L, Jiang Y, Zhou L, Huang Q, Pi R, Chen X J Neurosci Res. 2014 May 2. PMID: 24798871. Abstract
Protective effects of melatonin against mitochondrial injury in a mouse model of multiple sclerosis. Ragerdi Kashani I, Rajabi Z, Akbari M, Hassanzadeh G, Mohseni A, Eramsadati M K, Rafiee K, Beyer C, Kipp M, Zendedel A Exp Brain Res. 2014 May 6. PMID: 24798398. Abstract
Trunk kinematics during walking in persons with multiple sclerosis: The influence of body weight support. Swinnen E, Baeyens J-P, Pintens S, Van Nieuwenhoven J, Ilsbroukx S, Buyl R, Goossens M, Meeusen R, Kerckhofs E NeuroRehabilitation. 2014 May 5. PMID: 24796441. Abstract
Systemic Injection of Neural Stem/Progenitor Cells in Mice with Chronic EAE. Donegà M, Giusto E, Cossetti C, Schaeffer J, Pluchino S J Vis Exp. 2014(86). PMID: 24798882. Abstract
Autoimmune Hepatitis-like reaction developing in a patient treated with Interferon beta 1a. Mishra A, Guindi M, Kandel G, Streutker CJ Histopathology. 2014 May 5. PMID: 24796493. Abstract
Multiple sclerosis: The elevated antibody response to Epstein-Barr virus primarily targets, but is not confined to, the glycine-alanine repeat of Epstein-Barr nuclear antigen-1. Ruprecht K, Wunderlich B, Gieß R, Meyer P, Loebel M, Lenz K, Hofmann J, Rosche B, Wengert O, Paul F, et al. J Neuroimmunol. 2014 Apr 16. PMID: 24798244. Abstract
Minimal clinically important difference for change in comfortable gait speed of adults with pathology: a systematic review. Bohannon RW, Glenney SS J Eval Clin Pract. 2014 May 5. PMID: 24798823. Abstract
Comparative pharmacogenetics of multiple sclerosis: IFN-β versus glatiramer acetate. Kulakova OG, Tsareva E Y, Lvovs D, Favorov AV, Boyko AN, Favorova OO Pharmacogenomics. 2014 Apr; 15(5):679-85. PMID: 24798724. Abstract
Experiences of functional electrical stimulation (FES) and ankle foot orthoses (AFOs) for foot-drop in people with multiple sclerosis. Bulley C, Mercer TH, Hooper JE, Cowan P, Scott S, van der Linden ML Disabil Rehabil Assist Technol. 2014 May 6. PMID: 24796365. Abstract
Myelin Oligodendrocyte Glycoprotein (MOG35-55) Induced Experimental Autoimmune Encephalomyelitis (EAE) in C57BL/6 Mice. Bittner S, Afzali AM, Wiendl H, Meuth SG J Vis Exp. 2014(86). PMID: 24797125. Abstract
Quality of life in Polish patients with multiple sclerosis. Mitosek-Szewczyk K, Kułakowska A, Bartosik-Psujek H, Hożejowski R, Drozdowski W, Stelmasiak Z Adv Med Sci. 2014 Mar; 59(1):34-8. PMID: 24797971. Abstract
Multiple sclerosis care in Latin America. Rivera VM, Medina M T, Duron RM, Macias M A Neurology. 2014 May 6; 82(18):1660-1. PMID: 24799516. Abstract
Vitamin D and multiple sclerosis. Harandi A A, Harandi A A, Pakdaman H, Sahraian M A Iran J Neurol. 2014; 13(1):1-6. PMID: 24800040. Abstract
Prevalence of Lhermitte's sign in multiple sclerosis versus neuromyelitis optica. Etemadifar M, Mehrbod N, Dehghani L, Golabbakhsh A, Fereidan-Esfahani M, Akbari M, Nasr Z Iran J Neurol. 2014; 13(1):50-1. PMID: 24800049. Abstract
Dietary intake of nutrients and its correlation with fatigue in multiple sclerosis patients. Bitarafan S, Harirchian M-H, Nafissi S, Sahraian M-A, Togha M, Siassi F, Saedisomeolia A, Alipour E, Mohammadpour N, Chamary M, et al. Iran J Neurol. 2014; 13(1):28-32. PMID: 24800044. Abstract
Idazoxan reduces blood-brain barrier damage during experimental autoimmune encephalomyelitis in mouse. Wang X-S, Fang H-L, Chen Y, Liang S-S, Zhu Z-G, Zeng Q-Y, Li J, Xu H-Q, Shao B, He J-C, et al. Eur J Pharmacol. 2014 May 2. PMID: 24797785. Abstract
Level of attitude toward complementary and alternative medicine among Iranian patients with multiple sclerosis. Harirchian M H, Sahraian M A, Hosseinkhani A, Amirzargar N Iran J Neurol. 2014; 13(1):13-8. PMID: 24800042. Abstract
Diffusion tensor MRI as a biomarker in axonal and myelin damage. Aung W Y, Mar S, Benzinger T L Imaging Med. 2013 Oct 1; 5(5):427-440. PMID: 24795779. Abstract
Magnetic resonance outcome measures in multiple sclerosis trials: time to rethink? Filippi M, Preziosa P, Rocca MA Curr Opin Neurol. 2014 Jun; 27(3):290-9. PMID: 24792339. Abstract
The Impact of Dynamic Balance Measures on Walking Performance in Multiple Sclerosis. Fritz NE, Marasigan R ER, Calabresi PA, Newsome SD, Zackowski KM Neurorehabil Neural Repair. 2014 May 1. PMID: 24795162. Abstract
Pegylated interferon beta-1a for relapsing-remitting multiple sclerosis (ADVANCE): a randomised, phase 3, double-blind study. Calabresi PA, Kieseier BC, Arnold DL, Balcer LJ, Boyko A, Pelletier J, Liu S, Zhu Y, Seddighzadeh A, Hung S, et al. Lancet Neurol. 2014 Apr 30. PMID: 24794721. Abstract
Activation-induced cell death in T lymphocytes from multiple sclerosis patients. Moreno M, Negrotto L, Río J, Moubarak R, Martín I, Bustamante MF, Comella JX, Vidal-Jordana A, Pérez-Boza J, Montalban X, et al. J Neuroimmunol. 2014 Apr 16. PMID: 24793898. Abstract
Mode of action and clinical studies with alemtuzumab. Jones JL, Coles AJ Exp Neurol. 2014 May 2. PMID: 24792641. Abstract
Determinants of iron accumulation in deep grey matter of multiple sclerosis patients. Ropele S, Kilsdonk ID, Wattjes MP, Langkammer C, de Graaf WL, Frederiksen JL, Larsson HB, Yiannakas M, Wheeler-Kingshott C A, Enzinger C, et al. Mult Scler. 2014 Apr 30. PMID: 24787429. Abstract
No association between CCL2 gene polymorphisms and risk of inflammatory demyelinating diseases in a Korean population. Namgoong S, Bae JS, Cheong HS, Kim J-H, Kim JY, Kim LH, Kim HJ, Shin HD Tissue Antigens. 2014 May 2. PMID: 24786287. Abstract
Effects of cannabis on cognition in patients with MS: A psychometric and MRI study. Pavisian B, Macintosh BJ, Szilagyi G, Staines RW, O'Connor P, Feinstein A Neurology. 2014 Apr 30. PMID: 24789863. Abstract
Stimulated PBMC-produced IFN-γ and TNF-α are associated with altered relapse risk in multiple sclerosis: results from a prospective cohort study. Simpson S, Stewart N, van der Mei I, Otahal P, Charlesworth J, Ponsonby A-L, Blizzard L, Dwyer T, Pittas F, Gies P, et al. J Neurol Neurosurg Psychiatry. 2014 May 1. PMID: 24790215. Abstract
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis. Prosperini L, De Angelis F, De Angelis R, Fanelli F, Pozzilli C J Neurol Neurosurg Psychiatry. 2014 Apr 30. PMID: 24790213. Abstract
Fatigue and health-related quality of life in relapsing-remitting multiple sclerosis after 2 years glatiramer acetate treatment are predicted by changes at 6 months: an observational multi-center study. Jongen P J, Lehnick D, Koeman J, Frequin S, Heersema D, Kornips B, Schyns-Soeterboek A, Visser LH, Schiphof P, Valkenburg A, et al. J Neurol. 2014 May 3. Epub 2014 May 03. PMID: 24792727. Abstract
Retinal architecture and mfERG: Optic nerve head component response characteristics in MS. Schnurman ZS, Frohman TC, Beh SC, Conger D, Conger A, Saidha S, Galetta S, Calabresi PA, Green AJ, Balcer LJ, et al. Neurology. 2014 Apr 30. PMID: 24789865. Abstract
Teriflunomide - a new oral agent for multiple sclerosis treatment. Antochi F Maedica (Buchar). 2013 Sep; 8(4):404-5. PMID: 24790678. Abstract
Paroxysmal dysarthria-ataxia in remitting-relapsing Bickerstaff's-like encephalitis. Piffer S, Turri G, Acler M, Richelli S, Cerini R, Fiaschi A, Monaco S, Bonetti B J Neurol Sci. 2014 Apr 13. PMID: 24780438. Abstract
An adult case of multiphasic disseminated encephalomyelitis manifesting with optic neuritis. Yang H-Q, Zhao W-C, Feng S-M, Ma J-J Intern Med. 2014; 53(9):1011-5. Epub 2014 May 01. PMID: 24785895. Abstract
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis. Jongen P J, Wesnes K, van Geel B, Pop P, Sanders E, Schrijver H, Visser LH, Gilhuis JH, Sinnige LG, Brands AM, et al. PLoS One. 2014; 9(5):e96444. Epub 2014 May 01. PMID: 24787714. Abstract
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9. Zheng M, Wei J, Tang Y, Yang C, Wei Y, Yin X, Liu Q J Mol Neurosci. 2014 May 1. Epub 2014 May 01. PMID: 24788224. Abstract
miR-326 and miR-26a, two potential markers for diagnosis of relapse and remission phases in patient with relapsing-remitting multiple sclerosis. Honardoost M A, Kiani-Esfahani A, Ghaedi K, Etemadifar M, Salehi M Gene. 2014 Jul 10; 544(2):128-33. Epub 2014 Apr 30. PMID: 24792898. Abstract
Fumaric acid esters in psoriasis and multiple sclerosis. Zecca C, Caporro M, Adami M, Mainetti C, Gobbi C Clin Exp Dermatol. 2014 Jun; 39(4):488-91. Epub 2014 Apr 30. PMID: 24779791. Abstract
Levels of soluble TNF-RII are increased in serum of patients with primary progressive multiple sclerosis. Fissolo N, Cantó E, Vidal-Jordana A, Castilló J, Montalban X, Comabella M J Neuroimmunol. 2014 Jun 15; 271(1-2):56-9. Epub 2014 Apr 16. PMID: 24794503. Abstract
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis. Guerini FR, Clerici M, Cagliani R, Malhotra S, Montalban X, Forni D, Agliardi C, Riva S, Caputo D, Galimberti D, et al. J Neuroimmunol. 2014 Jun 15; 271(1-2):49-52. Epub 2014 Apr 16. PMID: 24794504. Abstract
The Symbol Digit Modalities Test is an effective cognitive screen in pediatric onset multiple sclerosis (MS). Charvet LE, Beekman R, Amadiume N, Belman AL, Krupp LB J Neurol Sci. 2014 Jun 15; 341(1-2):79-84. Epub 2014 Apr 13. PMID: 24792098. Abstract
Apolipoprotein E mediation of neuro-inflammation in a murine model of multiple sclerosis. Shin S, Walz KA, Archambault AS, Sim J, Bollman BP, Koenigsknecht-Talboo J, Cross AH, Holtzman DM, Wu GF J Neuroimmunol. 2014 Jun 15; 271(1-2):8-17. Epub 2014 Mar 29. PMID: 24794230. Abstract
Comparison of brain 3.0-T with 1.5-T MRI in patients with multiple sclerosis: A 6-month follow-up study. Kataoka H, Kiriyama T, Taoka T, Oba N, Takewa M, Eura N, Syobatake R, Kobayashi Y, Kumazawa M, Izumi T, et al. Clin Neurol Neurosurg. 2014 Jun; 121:55-8. Epub 2014 Mar 27. PMID: 24793476. Abstract
Oral dalfampridine improves standing balance detected at static posturography in multiple sclerosis. Prosperini L, Giannì C, Fortuna D, Marchetti M R, Pozzilli C Mult Scler Int. 2014; 2014:802307. Epub 2014 Mar 27. PMID: 24800078. Abstract
Correlations between MRI and Information Processing Speed in MS: A Meta-Analysis. Rao SM, Martin AL, Huelin R, Wissinger E, Khankhel Z, Kim E, Fahrbach K Mult Scler Int. 2014; 2014:975803. Epub 2014 Mar 25. PMID: 24795824. Abstract
Is there any relation between cervical cord plaques and discopathy in patients with multiple sclerosis? Nikseresht A, Sharifian M, Izadi S, Hamidian Jahromi A, Rezaianzadeh A Clin Neurol Neurosurg. 2014 Jun; 121:23-6. Epub 2014 Mar 19. PMID: 24793469. Abstract
Intermittent alien hand syndrome and callosal apraxia in multiple sclerosis: implications for interhemispheric communication. Lunardelli A, Sartori A, Mengotti P, Rumiati RI, Pesavento V Behav Neurol. 2014; 2014:873541. Epub 2014 Feb 18. PMID: 24803736. Abstract
Lessons learned from studies of natural resistance in murine experimental autoimmune encephalomyelitis. Tse HY, Li J, Zhao X, Chen F, Ho PP, Shaw MK Curr Trends Immunol. 2012; 13:1-12. PMID: 24795508. Abstract